Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study. (Q53376981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Genomic profiling of pediatric ALK-positive anaplastic large cell lymphoma: a Children's Cancer and Leukaemia Group Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

ALK-positive anaplastic large cell lymphoma

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Rifat Hamoudi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Joaquim Carreras

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Chris M Bacon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

G A Amos Burke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Catrin Youssif

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jan Goldenbogen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Maria Viskaduraki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yu-xin Cui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

Genes, Chromosomes and Cancer

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1018-1026

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19691112%20AND%20SRC:MED&resulttype=core&format=json

Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity

5 February 2020

cites work

1 reference

Coordinate expression and proliferative role of HOXB genes in activated adult T lymphocytes.

21 January 2018

1 reference

Testing for differences with the nonparametric Mann-Whitney U test.

21 January 2018

1 reference

Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma

21 January 2018

1 reference

Hox genes in hematopoiesis and leukemogenesis.

21 January 2018

1 reference

7 January 2021

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group

1 reference

7 January 2021

A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.

1 reference

7 January 2021

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

1 reference

7 January 2021

The anaplastic lymphoma kinase in the pathogenesis of cancer

1 reference

7 January 2021

Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese patients with Ki-1 anaplastic large cell lymphoma: Special emphasis on the tumor response to 13-Cis retinoic acid

1 reference

7 January 2021

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

1 reference

7 January 2021

NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner.

1 reference

7 January 2021

Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5)

1 reference

7 January 2021

Application of array CGH on archival formalin-fixed paraffin-embedded tissues including small numbers of microdissected cells.

1 reference

7 January 2021

Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma

1 reference

7 January 2021

High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.

1 reference

7 January 2021

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

7 January 2021

Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology group

1 reference

7 January 2021

Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.

1 reference

7 January 2021

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

1 reference

7 January 2021

Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma

1 reference

7 January 2021

What have we learnt from mouse models of NPM-ALK-induced lymphomagenesis?

1 reference

7 January 2021

Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells.

1 reference

7 January 2021

Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase

1 reference

7 January 2021

The NPM-ALK tyrosine kinase mimics TCR signalling pathways, inducing NFAT and AP-1 by RAS-dependent mechanisms

1 reference

7 January 2021

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

7 January 2021

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

1 reference

7 January 2021